Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

NCT03109249 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.

NCT NCT03109249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer
Lead sponsor
Sun Pharma Advanced Research Company Limited
Phase
Phase 1
Overall status
Completed
Start date
January 14, 2017
Completion date
October 4, 2018
Enrollment
142 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent or metastatic breast cancer